Editorial
Management of brain metastases in non-small cell lung cancer without actionable driver mutations—the need to dive deeper in the right ‘pool’
Translational Lung Cancer Research
2023;
12
(10)
:1966-1971
.
(31 October 2023)
Original Article
SLC22A3 that encodes organic cation transporter-3 is associated with prognosis and immunogenicity of human lung squamous cell carcinoma
Translational Lung Cancer Research
2023;
12
(10)
:1972-1986
.
(31 October 2023)
Safety and efficacy of thoracic radiotherapy combined with chemo-immunotherapy in patients with extensive-stage small cell lung cancer: a multicenter retrospective analysis
Translational Lung Cancer Research
2023;
12
(10)
:1987-2000
.
(31 October 2023)
Impact of RBM10 and PD-L1 expression on the prognosis of pathologic N1–N2 epidermal growth factor receptor mutant lung adenocarcinoma
Translational Lung Cancer Research
2023;
12
(10)
:2001-2014
.
(31 October 2023)
Impact of time-to-treatment on survival for early-stage non-small cell lung cancer in The Netherlands—a nationwide observational cohort study
Translational Lung Cancer Research
2023;
12
(10)
:2015-2029
.
(31 October 2023)
Clinical outcomes of KRAS-mutant non-small cell lung cancer under untargeted therapeutic regimes in the real world: a retrospective observational study
Translational Lung Cancer Research
2023;
12
(10)
:2030-2039
.
(31 October 2023)
Exploration of a novel prognostic model based on nomogram in non-small cell lung cancer patients with distant organ metastasis: implications for immunotherapy
Translational Lung Cancer Research
2023;
12
(10)
:2040-2054
.
(31 October 2023)
Recurrence prediction of lung adenocarcinoma using an immune gene expression and clinical data trained and validated support vector machine classifier
Translational Lung Cancer Research
2023;
12
(10)
:2055-2067
.
(31 October 2023)
Impact of lung cancer screening with low-dose chest computed tomography on an older population: a retrospective cohort study
Translational Lung Cancer Research
2023;
12
(10)
:2068-2082
.
(31 October 2023)
Exploring the efficacy of artificial neural networks in predicting lung cancer recurrence: a retrospective study based on patient records
Translational Lung Cancer Research
2023;
12
(10)
:2083-2097
.
(31 October 2023)
CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
Translational Lung Cancer Research
2023;
12
(10)
:2098-2112
.
(31 October 2023)
Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study
Translational Lung Cancer Research
2023;
12
(10)
:2113-2128
.
(31 October 2023)
Review Article
Biomarkers of lung cancer for screening and in never-smokers—a narrative review
Translational Lung Cancer Research
2023;
12
(10)
:2129-2145
.
(31 October 2023)
Erratum
Erratum to cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study
Translational Lung Cancer Research
2023;
12
(10)
:2146-2147
.
(31 October 2023)
